• Citer

Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer Center.

par Kaye, S B;Piccart-Gebhart, Martine ;Aapro, Matti;Kavanagh, J
Référence European journal of cancer, 31A Suppl 4, page (S14-S17)
Publication Publié, 1995

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Docetaxel in advanced ovarian cancer: preliminary results from three phase II trials. EORTC Early Clinical Trials Group and Clinical Screening Group, and the MD Anderson Cancer Center.
Auteur:	Kaye, S B; Piccart-Gebhart, Martine; Aapro, Matti; Kavanagh, J
Informations sur la publication:	European journal of cancer, 31A Suppl 4, page (S14-S17)
Statut de publication:	Publié, 1995
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	docetaxel
	iatrogenic disease
	ovarian neoplasms
	phase II clinical trials
MeSH keywords:	Adult
	Aged
	Antineoplastic Agents, Phytogenic -- therapeutic use
	Female
	Humans
	Middle Aged
	Ovarian Neoplasms -- drug therapy
	Paclitaxel -- analogs & derivatives
	Paclitaxel -- therapeutic use
	Taxoids
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/0959-8049(95)00361-L
	info:pii/095980499500361L
	info:scp/0028810460
	info:pmid/7577099